AOI Pharmaceuticals, Inc. Report issue

For profit Phase 2
Founded: New York NY United States (2002)
Status: Acquired by Keryx (2004) → now Akebia Therapeutics (2018)

Organization Overview

First Clinical Trial
2006
NCT00401011
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

AOI Pharmaceuticals, Inc

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Astrocytoma (Phase 2)

Glioma (Phase 2)

Multiple Myeloma (Phase 2)

Neoplasms, Plasma Cell (Phase 2)

Oligodendroglioma (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 5